Xeris Biopharma Holdings: Q1 Earnings Insights
Xeris Biopharma Holdings (NASDAQ:XERS) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Xeris Biopharma Holdings reported in-line EPS of $-0.25 versus an estimate of $-0.25.
Revenue was up $13.86 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.18 which was followed by a 3.05% increase in the share price the next day.
Here's a look at Xeris Biopharma Holdings's past performance:
|Quarter||Q4 2021||Q3 2021||Q2 2021||Q1 2021|
To track all earnings releases for Xeris Biopharma Holdings visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.